首页 > 最新文献

Arab Journal of Gastroenterology最新文献

英文 中文
Improved effects of the b-value for 2000 sec/mm2 DWI on an accurate qualitative and quantitative assessment of rectal cancer 提高2000秒/mm2 DWI b值对直肠癌准确定性和定量评估的效果。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-11-01 DOI: 10.1016/j.ajg.2023.09.001
Zhihua Lu , Kaijian Xia , Heng Jiang , Xiaoyan Weng , Mei Wu

Background and study objectives

A higher b-value Diffusion-weighted imaging (DWI) would improve the contrast between cancerous and noncancerous tissue. Apparent diffusion coefficient (ADC)-histogram analysis is a method that can provide statistical data and quantitative information on tumor heterogeneity. This study aimed to compare two high b-values (1000 and 2000 sec/mm2) DWI in tumor detection and diagnostic performance in identifying early-stage tumor rectal cancer.

Patients and methods

This blinded and blinded retrospective study involved 56 patients with rectal cancer and 45 patients. Two radiologists evaluated the qualitative detection parameters and quantitative parameters of the ADC evaluated histogram and compared them between two DWI sequences (b-value for 1000 sec/mm2 and 2000 sec/mm2). The characteristic curves were used to assess diagnostic administration for the ADC histogram in discriminating early-stage tumors.

Results

The b-value for 2000 sec/mm2 DWI significantly improved AUCs, sensitivity, specificity, and precision and decreased false-positive rate for detection compared to the b-value for 1000 sec/mm2 (p < 0.05). The mean and fifth percentile ADC value for stage I using the b-value for 1000 sec/mm2 DWI was significantly higher than stage ≥ II (p = 0.036II and 0.016 respectively), as the well as fifth, 10th, mean ADC of the fifth, 10th, and 25th ADC percentile at b-value for 2000 sec/mm2 (p = 0.031, 0.014, 0.035 and 0.025 respectively). The AUCs of the fifth percentile ADC at b-value for 2000 sec/mm2 DWI in both readers in differentiating the stage Ⅰ tumor were the highest (0.732 and 0.751).

Conclusion

The b-value for 2000 sec/mm2 DWI could improve the accurate detection of rectal cancer. The fifth percentile ADC at b-value for 2000 sec/mm2 sec/mm2 DWI was more useful for discriminating early stage than the b-value for 1000 sec/mm2 DWI.

背景和研究目的:更高的b值弥散加权成像(DWI)可以改善癌组织和非癌组织的对比。表观扩散系数-直方图分析是一种能够提供肿瘤异质性统计数据和定量信息的方法。本研究旨在比较两种高b值(1000和2000 sec/mm2) DWI对肿瘤的检测和对早期肿瘤直肠癌的诊断性能。患者和方法:本研究采用盲法和盲法回顾性研究,共纳入56例直肠癌患者和45例患者。两名放射科医师评估ADC评估直方图的定性检测参数和定量参数,并比较两个DWI序列(1000秒/mm2和2000秒/mm2的b值)。特征曲线用于评估ADC直方图在鉴别早期肿瘤中的诊断作用。结果:2000秒/mm2 DWI的b值与1000秒/mm2的b值相比,auc、灵敏度、特异度、精密度显著提高,假阳性率显著降低(p值显著高于≥II期(p = 0.036II和0.016),2000秒/mm2 b值的第5、第10、第5、第10和第25个ADC百分位数的平均ADC (p = 0.031、0.014、0.035和0.025)。在2000秒/mm2 DWI下,两名读者在诊断Ⅰ期肿瘤时,第5百分位ADC的b值auc最高(0.732和0.751)。结论:2000秒/mm2 DWI b值可提高直肠癌的准确检出率。在2000秒/mm2秒/mm2 DWI的b值下,第五个百分位ADC比1000秒/mm2 DWI的b值对早期诊断更有用。
{"title":"Improved effects of the b-value for 2000 sec/mm2 DWI on an accurate qualitative and quantitative assessment of rectal cancer","authors":"Zhihua Lu ,&nbsp;Kaijian Xia ,&nbsp;Heng Jiang ,&nbsp;Xiaoyan Weng ,&nbsp;Mei Wu","doi":"10.1016/j.ajg.2023.09.001","DOIUrl":"10.1016/j.ajg.2023.09.001","url":null,"abstract":"<div><h3>Background and study objectives</h3><p><span>A higher b-value Diffusion-weighted imaging (DWI) would improve the contrast between cancerous and noncancerous tissue. Apparent diffusion coefficient (ADC)-histogram analysis is a method that can provide statistical data and quantitative information on tumor heterogeneity. This study aimed to compare two high b-values (1000 and 2000 sec/mm</span><sup>2</sup><span><span>) DWI in tumor detection and diagnostic performance in identifying early-stage tumor </span>rectal cancer.</span></p></div><div><h3>Patients and methods</h3><p>This blinded and blinded retrospective study involved 56 patients with rectal cancer and 45 patients. Two radiologists evaluated the qualitative detection parameters and quantitative parameters of the ADC evaluated histogram and compared them between two DWI sequences (b-value for 1000 sec/mm<sup>2</sup> and 2000 sec/mm<sup>2</sup>). The characteristic curves were used to assess diagnostic administration for the ADC histogram in discriminating early-stage tumors.</p></div><div><h3>Results</h3><p>The b-value for 2000 sec/mm<sup>2</sup> DWI significantly improved AUCs, sensitivity, specificity, and precision and decreased false-positive rate for detection compared to the b-value for 1000 sec/mm<sup>2</sup> (<em>p</em> &lt; 0.05). The mean and fifth percentile ADC value for stage I using the b-value for 1000 sec/mm<sup>2</sup> DWI was significantly higher than stage ≥ II (<em>p</em> = 0.036II and 0.016 respectively), as the well as fifth, 10th, mean ADC of the fifth, 10th, and 25th ADC percentile at b-value for 2000 sec/mm<sup>2</sup> (<em>p</em> = 0.031, 0.014, 0.035 and 0.025 respectively). The AUCs of the fifth percentile ADC at b-value for 2000 sec/mm<sup>2</sup> DWI in both readers in differentiating the stage Ⅰ tumor were the highest (0.732 and 0.751).</p></div><div><h3>Conclusion</h3><p>The b-value for 2000 sec/mm<sup>2</sup> DWI could improve the accurate detection of rectal cancer. The fifth percentile ADC at b-value for 2000 sec/mm<sup>2</sup> sec/mm<sup>2</sup> DWI was more useful for discriminating early stage than the b-value for 1000 sec/mm<sup>2</sup> DWI.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138292126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
B-cell-specific Moloney murine leukemia virus integration site 1 knockdown impairs adriamycin resistance of gastric cancer cells B细胞特异性Moloney小鼠白血病病毒整合位点1的敲低削弱了癌症细胞对阿霉素的耐药性。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2023.02.004
Ning Ma, Sihui Zhao, Wei Yang, Yongfang Wang

Background and study aims

The B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) is associated with the progression of gastric cancer (GC). However, its role in drug resistance of gastric cancer stem cell (GCSC) remains unclear. This study aimed to explore the biological function of BMI-1 in GC cells and its role in drug resistance of GCSCs.

Patients and methods

We assessed BMI-1 expression in the GEPIA database and in our collected samples from patients with GC. We silenced BMI-1 using siRNA to study the cell proliferation and migration of GC cells. We also used Hoechst 33342 staining to verify the effect of adriamycin (ADR) on side population (SP) cells, and measured the effects of BMI-1 on the expression of N-cadherin, E-cadherin, and drug-resistance-related proteins (multidrug resistance mutation 1 and lung resistance-related protein). Finally, we analyzed BMI-1-related proteins uing the STRING and GEPIA databases.

Results

BMI-1 mRNA was upregulated in GC tissues and cell lines, especially in MKN-45 and HGC-27 cells. Silencing BMI-1 reduced the proliferation and migration of GC cells. Knocking down BMI-1 significantly decreased epithelial-mesenchymal transition progression, expression levels of drug-resistant proteins, and the number of SP cells in ADR-treated GC cells. Bioinformatics analysis showed that EZH2, CBX8, CBX4, and SUZ12 were positively correlated with BMI-1 in GC tissues.

Conclusion

Our study demonstrates that BMI-1 affects the cellular activity, proliferation, migration, and invasion of GC cells. Silencing the BMI-1 gene significantly reduces the number of SP cells and the expression of drug-resistant proteins in ADR-treated GC cells. We speculate that inhibition of BMI-1 increases the drug resistance of GC cells by affecting GCSCs, and that EZH2, CBX8, CBX4, and SUZ12 may participate in BMI-1-induced enhancement of GCSC-like phenotype and viability.

背景与研究目的:B细胞特异性Moloney小鼠白血病病毒整合位点1(BMI-1)与癌症(GC)的进展有关。然而,其在癌症干细胞(GCSC)耐药性中的作用尚不清楚。本研究旨在探讨BMI-1在GC细胞中的生物学功能及其在GC耐药性中的作用。患者和方法:我们在GEPIA数据库和收集的GC患者样本中评估了BMI-1的表达。我们使用siRNA沉默BMI-1来研究GC细胞的细胞增殖和迁移。我们还使用Hoechst 33342染色来验证阿霉素(ADR)对副群(SP)细胞的影响,并测量BMI-1对N-钙粘蛋白、E-钙粘蛋白和耐药性相关蛋白(多药耐药性突变1和肺耐药相关蛋白)表达的影响。最后,我们在STRING和GEPIA数据库中分析了BMI-1相关蛋白。结果:BMI-1 mRNA在GC组织和细胞系中上调,尤其是在MKN-45和HGC-27细胞中。沉默BMI-1降低GC细胞的增殖和迁移。敲除BMI-1显著降低ADR处理的GC细胞中上皮-间质转化进程、耐药蛋白的表达水平和SP细胞的数量。生物信息学分析表明,EZH2、CBX8、CBX4和SUZ12与GC组织中的BMI-1呈正相关。结论:我们的研究表明,BMI-1影响GC细胞的细胞活性、增殖、迁移和侵袭。在ADR处理的GC细胞中,沉默BMI-1基因显著减少SP细胞的数量和耐药蛋白的表达。我们推测,BMI-1的抑制通过影响GCSC增加GC细胞的耐药性,并且EZH2、CBX8、CBX4和SUZ12可能参与BMI-1诱导的GCSC样表型和生存能力的增强。
{"title":"B-cell-specific Moloney murine leukemia virus integration site 1 knockdown impairs adriamycin resistance of gastric cancer cells","authors":"Ning Ma,&nbsp;Sihui Zhao,&nbsp;Wei Yang,&nbsp;Yongfang Wang","doi":"10.1016/j.ajg.2023.02.004","DOIUrl":"10.1016/j.ajg.2023.02.004","url":null,"abstract":"<div><h3>Background and study aims</h3><p><span>The B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) is associated with the progression of gastric cancer (GC). However, its role in </span>drug<span> resistance of gastric cancer stem cell (GCSC) remains unclear. This study aimed to explore the biological function of BMI-1 in GC cells and its role in drug resistance of GCSCs.</span></p></div><div><h3>Patients and methods</h3><p><span><span>We assessed BMI-1 expression in the GEPIA database and in our collected samples from patients with GC. We silenced BMI-1 using siRNA to study the </span>cell proliferation and migration of GC cells. We also used </span>Hoechst 33342<span> staining to verify the effect of adriamycin<span> (ADR) on side population (SP) cells, and measured the effects of BMI-1 on the expression of N-cadherin, E-cadherin, and drug-resistance-related proteins (multidrug resistance mutation 1 and lung resistance-related protein). Finally, we analyzed BMI-1-related proteins uing the STRING and GEPIA databases.</span></span></p></div><div><h3>Results</h3><p>BMI-1 mRNA was upregulated in GC tissues and cell lines, especially in MKN-45 and HGC-27 cells. Silencing BMI-1 reduced the proliferation and migration of GC cells. Knocking down BMI-1 significantly decreased epithelial-mesenchymal transition progression, expression levels of drug-resistant proteins, and the number of SP cells in ADR-treated GC cells. Bioinformatics analysis showed that EZH2, CBX8, CBX4, and SUZ12 were positively correlated with BMI-1 in GC tissues.</p></div><div><h3>Conclusion</h3><p>Our study demonstrates that BMI-1 affects the cellular activity, proliferation, migration, and invasion of GC cells. Silencing the BMI-1 gene significantly reduces the number of SP cells and the expression of drug-resistant proteins in ADR-treated GC cells. We speculate that inhibition of BMI-1 increases the drug resistance of GC cells by affecting GCSCs, and that EZH2, CBX8, CBX4, and SUZ12 may participate in BMI-1-induced enhancement of GCSC-like phenotype and viability.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10839280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
AC125611.3 promotes the progression of colon cancer by recruiting DKC1 to stabilize CTNNB1 AC125611.3通过募集DKC1稳定CTNNB1来促进癌症的进展。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2022.10.013
Hanqing Tang , Yuyu Dou , Yiliang Meng , Qinglan Lu , Lingling Liang

Background and study aims

Previous studies have suggested that lncRNAs impact cancer progression. The lncRNA AC125611.3 (also referred to as RP11-161H23.5) is highly expressed in colon cancer but rarely studied; understanding its regulation may provide novel insights on treating colon cancer.

Materials and methods

qRT-PCR was performed to quantify RNAs. CCK-8 and EdU assays were performed to assess cell proliferation. Western blot analysis was used to detect levels of proteins related to cell apoptosis and EMT. Wound healing assay and Transwell invasion assay were conducted to evaluate cell migratory and invasive capabilities, respectively. Luciferase reporter assay, RIP assay, and pull-down assay were used to verify RNA-RNA and RNA-protein interactions.

Results

AC125611.3 was highly overexpressed in colon cancer cells. AC125611.3 depletion curbed cell proliferative, invasive, migratory, and EMT processes while enhancing apoptosis. Furthermore, AC125611.3 activated the Wnt signaling pathway in colon cancer cells by regulating catenin beta-1 (CTNNB1). Moreover, AC125611.3 recruited dyskeratosis congenita 1 (DKC1) to stabilize CTNNB1.

Conclusion

AC125611.3 recruits DKC1 to stabilize CTNNB1 and activate Wnt signaling, thereby promoting the progression of colon cancer.

背景和研究目的:先前的研究表明lncRNA影响癌症的进展。lncRNA AC125611.3(也称为RP11-161H23.5)在癌症中高表达,但很少研究;了解其调节可能为治疗结肠癌癌症提供新的见解。材料和方法:采用qRT-PCR对RNA进行定量。进行CCK-8和EdU测定以评估细胞增殖。Western印迹分析用于检测与细胞凋亡和EMT相关的蛋白质水平。分别进行伤口愈合试验和Transwell侵袭试验来评估细胞迁移和侵袭能力。荧光素酶报告基因测定法、RIP测定法和下拉测定法用于验证RNA-RNA和RNA-蛋白质的相互作用。结果:AC125611.3在结肠癌癌症细胞中高表达。AC125611.3耗竭抑制了细胞增殖、侵袭、迁移和EMT过程,同时增强了细胞凋亡。此外,AC125611.3通过调节连环蛋白β-1(CTNNB1)激活了癌症细胞中的Wnt信号通路。此外,AC125611.3招募先天性角化病1(DKC1)稳定CTNNB1。
{"title":"AC125611.3 promotes the progression of colon cancer by recruiting DKC1 to stabilize CTNNB1","authors":"Hanqing Tang ,&nbsp;Yuyu Dou ,&nbsp;Yiliang Meng ,&nbsp;Qinglan Lu ,&nbsp;Lingling Liang","doi":"10.1016/j.ajg.2022.10.013","DOIUrl":"10.1016/j.ajg.2022.10.013","url":null,"abstract":"<div><h3>Background and study aims</h3><p><span>Previous studies have suggested that lncRNAs impact cancer progression. The lncRNA AC125611.3 (also referred to as RP11-161H23.5) is highly expressed in </span>colon cancer but rarely studied; understanding its regulation may provide novel insights on treating colon cancer.</p></div><div><h3>Materials and methods</h3><p>qRT-PCR was performed to quantify RNAs. CCK-8 and EdU assays were performed to assess cell proliferation<span><span><span><span>. Western blot analysis was used to detect levels of proteins related to cell </span>apoptosis and </span>EMT<span>. Wound healing assay and Transwell invasion assay were conducted to evaluate cell migratory and invasive capabilities, respectively. Luciferase reporter assay, </span></span>RIP assay, and pull-down assay were used to verify RNA-RNA and RNA-protein interactions.</span></p></div><div><h3>Results</h3><p><span>AC125611.3 was highly overexpressed in colon cancer cells. AC125611.3 depletion curbed cell proliferative, invasive, migratory, and EMT processes while enhancing apoptosis. Furthermore, AC125611.3 activated the Wnt signaling pathway in colon cancer cells by regulating catenin beta-1 (CTNNB1). Moreover, AC125611.3 recruited </span>dyskeratosis congenita 1 (DKC1) to stabilize CTNNB1.</p></div><div><h3>Conclusion</h3><p>AC125611.3 recruits DKC1 to stabilize CTNNB1 and activate Wnt signaling, thereby promoting the progression of colon cancer.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10178299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Phylogenetic groups and antimicrobial resistance characteristics of Escherichia coli strains isolated from clinical samples in North Iran” [Arab J. Gastroenterol. 23 (2022) 102–107] 更正“从北伊朗临床样本中分离的大肠杆菌菌株的系统发育群和抗微生物耐药性特征”[Arab J.Gastroenterol.23(2022)102-107]。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2023.05.002
Maryam Haghighatpanah , Habib Zeighami , Amir Sasan Mozaffari Nejad , Nayyereh Hajipour
{"title":"Corrigendum to “Phylogenetic groups and antimicrobial resistance characteristics of Escherichia coli strains isolated from clinical samples in North Iran” [Arab J. Gastroenterol. 23 (2022) 102–107]","authors":"Maryam Haghighatpanah ,&nbsp;Habib Zeighami ,&nbsp;Amir Sasan Mozaffari Nejad ,&nbsp;Nayyereh Hajipour","doi":"10.1016/j.ajg.2023.05.002","DOIUrl":"10.1016/j.ajg.2023.05.002","url":null,"abstract":"","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9965510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis 溃疡性结肠炎患者血浆可溶性尿激酶纤溶酶原激活物受体(SuPAR)水平的评估。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2023.03.001
Huriye Erbak Yılmaz , Saliha Aksun , Süleyman Günay , Ferhan Elmalı , Cem Çekiç

Background and study aim

Soluble urokinase plasminogen activator receptor (SuPAR), a soluble form of the urokinase-type plasminogen activator receptor, is a biomarker produced by macrophages, monocytes, neutrophils, active T cells, endothelial cells, and circulating tumor cells. SuPAR is a novel biomarker showing altered inflammation in many inflammatory diseases. This study aims to investigate the SuPAR level in ulcerative colitis (UC) patients, and to evaluate the SuPAR level in active, and remission patients.

Patients and methods

Patient and healthy control SuPAR levels were analyzed by immunoassay method. SuPAR levels between UC patients and control group were compared. The difference between SuPAR levels in patients with active UC and UC in remission was analyzed. The relationship between C-reactive protein level, Total Mayo score, Mayo Endoscopic score used to predict disease activity, and amount of SuPAR were evaluated.

Results

SuPAR levels were determined in the UC patient group (2170,3 ± 121,0 pg/ml), and healthy controls (2130,7 ± 164,8 pg/ml) (p = 0. 805). Median SuPAR levels were determined in moderate UC (2479 pg/ml), mild UC (1944 pg/ml), and patients in remission (1774 pg/ml) (p = 0,207). There were no significant relationships between SuPAR levels and CRP levels, Total Mayo score, disease duration in the UC group (r = 0.177, r = 0.267, and r = 0,007; respectively p > 0.05). A slightly positive correlation was found between Mayo Endoscopic Score and SuPAR level (r = 0.303; p = 0.031).

Conclusion

SuPAR is of limited value in the diagnosis of ulcerative colitis and in the assessment of disease activation.

背景和研究目的:可溶性尿激酶纤溶酶原激活物受体(SuPAR)是尿激酶型纤溶酶原激活剂受体的一种可溶性形式,是由巨噬细胞、单核细胞、中性粒细胞、活性T细胞、内皮细胞和循环肿瘤细胞产生的生物标志物。SuPAR是一种新的生物标志物,在许多炎症性疾病中显示炎症的改变。本研究旨在调查溃疡性结肠炎(UC)患者的SuPAR水平,并评估活动期和缓解期患者的SuPAR水平。患者和方法:采用免疫测定法分析患者和健康对照组的SuPAR水平。比较UC患者和对照组的SuPAR水平。分析活动期UC患者和缓解期UC患者的SuPAR水平之间的差异。评估C反应蛋白水平、Mayo总分、用于预测疾病活动性的Mayo内镜评分和SuPAR量之间的关系。结果:UC患者组(2170,3±121,0pg/ml)和健康对照组(2130,7±164,8pg/ml)的SuPAR水平均得到测定(p=0。805)。测定中度UC(2479 pg/ml)、轻度UC(1944 pg/ml)和缓解期患者(1774 pg/ml)的中位SuPAR水平(p=0.007)。SuPAR水平与CRP水平、总Mayo评分、总代谢率和总代谢率之间没有显著关系,UC组的病程(r=0.177,r=0.267,r=0007;分别p>0.05)。Mayo内窥镜评分与SuPAR水平呈正相关(r=0.303;p=0.031)。结论:SuPAR在溃疡性结肠炎的诊断和疾病激活评估中的价值有限。
{"title":"Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis","authors":"Huriye Erbak Yılmaz ,&nbsp;Saliha Aksun ,&nbsp;Süleyman Günay ,&nbsp;Ferhan Elmalı ,&nbsp;Cem Çekiç","doi":"10.1016/j.ajg.2023.03.001","DOIUrl":"10.1016/j.ajg.2023.03.001","url":null,"abstract":"<div><h3>Background and study aim</h3><p><span><span><span>Soluble urokinase plasminogen activator receptor (SuPAR), a soluble form of the urokinase-type plasminogen activator receptor, is a biomarker produced by macrophages, </span>monocytes, </span>neutrophils<span>, active T cells<span><span>, endothelial cells, and </span>circulating tumor cells<span>. SuPAR is a novel biomarker showing altered inflammation in many inflammatory diseases. This study aims to investigate the SuPAR level in </span></span></span></span>ulcerative colitis (UC) patients, and to evaluate the SuPAR level in active, and remission patients.</p></div><div><h3>Patients and methods</h3><p><span>Patient and healthy control SuPAR levels were analyzed by immunoassay method. SuPAR levels between UC patients and control group were compared. The difference between SuPAR levels </span>in patients with active UC and UC in remission was analyzed. The relationship between C-reactive protein level, Total Mayo score, Mayo Endoscopic score used to predict disease activity, and amount of SuPAR were evaluated.</p></div><div><h3>Results</h3><p>SuPAR levels were determined in the UC patient group (2170,3 ± 121,0 pg/ml), and healthy controls (2130,7 ± 164,8 pg/ml) (p = 0. 805). Median SuPAR levels were determined in moderate UC (2479 pg/ml), mild UC (1944 pg/ml), and patients in remission (1774 pg/ml) (p = 0,207). There were no significant relationships between SuPAR levels and CRP levels, Total Mayo score, disease duration in the UC group (r = 0.177, r = 0.267, and r = 0,007; respectively p &gt; 0.05). A slightly positive correlation was found between Mayo Endoscopic Score and SuPAR level (r = 0.303; p = 0.031).</p></div><div><h3>Conclusion</h3><p>SuPAR is of limited value in the diagnosis of ulcerative colitis and in the assessment of disease activation.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9659211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ChatGPT’s ability to comprehend and answer cirrhosis related questions in Arabic ChatGPT用阿拉伯语理解和回答肝硬化相关问题的能力。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2023.08.001
Jamil S. Samaan , Yee Hui Yeo , Wee Han Ng , Peng-Sheng Ting , Hirsh Trivedi , Aarshi Vipani , Ju Dong Yang , Omer Liran , Brennan Spiegel , Alexander Kuo , Walid S. Ayoub

Background and study aims

Cirrhosis is a chronic progressive disease which requires complex care. Its incidence is rising in the Arab countries making it the 7th leading cause of death in the Arab League in 2010. ChatGPT is a large language model with a growing body of literature demonstrating its ability to answer clinical questions. We examined ChatGPT’s accuracy in responding to cirrhosis related questions in Arabic and compared its performance to English.

Materials and methods

ChatGPTs responses to 91 questions in Arabic and English were graded by a transplant hepatologist fluent in both languages. Accuracy of responses was assessed using the scale: 1. Comprehensive, 2. Correct but inadequate, 3. Mixed with correct and incorrect/outdated data, and 4. Completely incorrect. Accuracy of Arabic compared to English responses was assessed using the scale: 1. Arabic response is more accurate, 2. Similar accuracy, 3. Arabic response is less accurate.

Results

The model provided 22 (24.2%) comprehensive, 44 (48.4%) correct but inadequate, 13 (14.3%) mixed with correct and incorrect/outdated data and 12 (13.2%) completely incorrect Arabic responses. When comparing the accuracy of Arabic and English responses, 9 (9.9%) of the Arabic responses were graded as more accurate, 52 (57.1%) similar in accuracy and 30 (33.0%) as less accurate compared to English.

Conclusion

ChatGPT has the potential to serve as an adjunct source of information for Arabic speaking patients with cirrhosis. The model provided correct responses in Arabic to 72.5% of questions, although its performance in Arabic was less accurate than in English. The model produced completely incorrect responses to 13.2% of questions, reinforcing its potential role as an adjunct and not replacement of care by licensed healthcare professionals. Future studies to refine this technology are needed to help Arabic speaking patients with cirrhosis across the globe understand their disease and improve their outcomes.

背景和研究目的:肝硬化是一种需要复杂护理的慢性进行性疾病。它在阿拉伯国家的发病率正在上升,使其成为2010年阿拉伯联盟第7大死亡原因。ChatGPT是一个大型语言模型,越来越多的文献证明了它回答临床问题的能力。我们检查了ChatGPT在回答阿拉伯语肝硬化相关问题方面的准确性,并将其表现与英语进行了比较。材料和方法:ChatGPT对91个阿拉伯语和英语问题的回答由一位精通两种语言的移植肝病学家进行了评分。使用量表评估了回答的准确性:1。综合,2。正确但不充分,3。与正确和不正确/过时的数据混合,以及4。完全不正确。阿拉伯语与英语回答的准确性使用量表进行评估:1。阿拉伯语的回答更准确,2。类似的准确性,3。阿拉伯语的回答不太准确。结果:该模型提供了22个(24.2%)全面的,44个(48.4%)正确但不充分的,13个(14.3%)混合了正确和不正确/过时的数据,12个(13.2%)完全不正确的阿拉伯语回答。当比较阿拉伯语和英语回答的准确性时,与英语相比,9个(9.9%)阿拉伯语回答被评为更准确,52个(57.1%)准确性相似,30个(33.0%)准确性较低。结论:ChatGPT有潜力作为阿拉伯语肝硬化患者的辅助信息来源。该模型对72.5%的问题提供了正确的阿拉伯语回答,尽管其阿拉伯语表现不如英语准确。该模型对13.2%的问题做出了完全错误的回答,强化了其作为辅助而非取代持照医疗专业人员护理的潜在作用。需要进一步完善这项技术的研究,以帮助全球讲阿拉伯语的肝硬化患者了解他们的疾病并改善他们的预后。
{"title":"ChatGPT’s ability to comprehend and answer cirrhosis related questions in Arabic","authors":"Jamil S. Samaan ,&nbsp;Yee Hui Yeo ,&nbsp;Wee Han Ng ,&nbsp;Peng-Sheng Ting ,&nbsp;Hirsh Trivedi ,&nbsp;Aarshi Vipani ,&nbsp;Ju Dong Yang ,&nbsp;Omer Liran ,&nbsp;Brennan Spiegel ,&nbsp;Alexander Kuo ,&nbsp;Walid S. Ayoub","doi":"10.1016/j.ajg.2023.08.001","DOIUrl":"10.1016/j.ajg.2023.08.001","url":null,"abstract":"<div><h3>Background and study aims</h3><p>Cirrhosis is a chronic progressive disease which requires complex care. Its incidence is rising in the Arab countries making it the 7th leading cause of death in the Arab League in 2010. ChatGPT is a large language model with a growing body of literature demonstrating its ability to answer clinical questions. We examined ChatGPT’s accuracy in responding to cirrhosis related questions in Arabic and compared its performance to English.</p></div><div><h3>Materials and methods</h3><p>ChatGPTs responses to 91 questions in Arabic and English were graded by a transplant hepatologist fluent in both languages. Accuracy of responses was assessed using the scale: 1. Comprehensive, 2. Correct but inadequate, 3. Mixed with correct and incorrect/outdated data, and 4. Completely incorrect.<!--> <!-->Accuracy of Arabic compared to English responses was assessed using the scale: 1. Arabic response is more accurate, 2. Similar accuracy, 3. Arabic response is less accurate.</p></div><div><h3>Results</h3><p>The model provided 22 (24.2%) comprehensive, 44 (48.4%) correct but inadequate, 13 (14.3%) mixed with correct and incorrect/outdated data and 12 (13.2%) completely incorrect Arabic responses. When comparing the accuracy of Arabic and English responses, 9 (9.9%) of the Arabic responses were graded as more accurate, 52 (57.1%) similar in accuracy and 30 (33.0%) as less accurate compared to English.</p></div><div><h3>Conclusion</h3><p>ChatGPT has the potential to serve as an adjunct source of information for Arabic speaking patients with cirrhosis. The model provided correct responses in Arabic to 72.5% of questions, although its performance in Arabic was less accurate than in English. The model produced completely incorrect responses to 13.2% of questions, reinforcing its potential role as an adjunct and not replacement of care by licensed healthcare professionals. Future studies to refine this technology are needed to help Arabic speaking patients with cirrhosis across the globe understand their disease and improve their outcomes.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10170769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Streptococcus gallolyticus infection: A neglected marker for colorectal cancer? 溶没食子酸链球菌感染:大肠癌的一个被忽视的标志物?
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2023.02.002
Che Muhammad Khairul Hisyam Bin Ismail , Edre Bin Mohammad Aidid , Hairul Aini Binti Hamzah , Mohd Shaiful Ehsan Bin Shalihin , Azmi Bin Md Nor

Background and study aims

Colorectal cancer (CRC) is the second most common cancer in Malaysia and mostly detected at advanced stages due to lack of awareness of CRC symptoms and signs. CRC pathogenesis is multifactorial, and there is ambiguous evidence on association of Streptococcus gallolyticus infection with CRC that needs further attention.

Thus, a case–control study was conducted to determine whether S. gallolyticus infection is a predictor for CRC occurrence among patients attending Sultan Ahmad Shah Medical Centre@IIUM (SASMEC@IIUM).

Patients and methods

A total of 33 stool samples from patients diagnosed with CRC and 80 from patients without CRC attending surgical clinic of SASMEC@IIUM were collected and analyzed with iFOBT test and PCR assay to detect S. gallolyticus.

Results

In this study, the proportion of S. gallolyticus infection was higher among patients with CRC (48.5%) compared with the control group (20%). Univariate analysis shows that occult blood in stool, S. gallolyticus infection and family history were significantly associated with the development of CRC (P < 0.05). Using the multivariate logistic regression model, positive stool PCR for S. gallolyticus had the lowest relative standard error and almost five times the odds of developing CRC after adjusting other factors (adjusted odds ratio = 4.7, 95% confidence interval = 1.7–12.6, relative standard error = 59.6%).

Conclusion

This finding suggests that S. gallolyticus infection was the strongest predictor of CRC’s development in our study and potentially serves as a predictive marker for early detection of disease progression.

背景和研究目的:癌症是马来西亚第二常见的癌症,由于缺乏对结直肠癌症状和体征的认识,大多在晚期发现。CRC的发病机制是多因素的,有不明确的证据表明溶没食子链球菌感染与CRC有关,需要进一步关注。因此,进行了一项病例对照研究,以确定溶没食子酸链球菌感染是否是Sultan Ahmad Shah Medical就诊患者CRC发生的预测因素Centre@IIUM(SASMEC@IIUM).患者和方法:共有33份来自诊断为CRC的患者的粪便样本和80份来自参加SASMEC@IIUM收集并用iFOBT试验和PCR分析来检测溶没食子酸链球菌。结果:在本研究中,CRC患者中溶没食子酸链球菌感染的比例(48.5%)高于对照组(20%)。单因素分析表明,粪便潜血、溶没食子酸链球菌感染和家族史与CRC的发展显著相关(P结论:这一发现表明,在我们的研究中,溶没食子酸杆菌感染是CRC发展的最强预测因素,并可能成为早期检测疾病进展的预测标志。
{"title":"Streptococcus gallolyticus infection: A neglected marker for colorectal cancer?","authors":"Che Muhammad Khairul Hisyam Bin Ismail ,&nbsp;Edre Bin Mohammad Aidid ,&nbsp;Hairul Aini Binti Hamzah ,&nbsp;Mohd Shaiful Ehsan Bin Shalihin ,&nbsp;Azmi Bin Md Nor","doi":"10.1016/j.ajg.2023.02.002","DOIUrl":"10.1016/j.ajg.2023.02.002","url":null,"abstract":"<div><h3>Background and study aims</h3><p>Colorectal cancer (CRC) is the second most common cancer in Malaysia and mostly detected at advanced stages due to lack of awareness of CRC symptoms and signs. CRC pathogenesis is multifactorial, and there is ambiguous evidence on association of <span><em>Streptococcus gallolyticus</em></span> infection with CRC that needs further attention.</p><p>Thus, a case–control study was conducted to determine whether <em>S. gallolyticus</em> infection is a predictor for CRC occurrence among patients attending Sultan Ahmad Shah Medical Centre@IIUM (SASMEC@IIUM).</p></div><div><h3>Patients and methods</h3><p>A total of 33 stool samples from patients diagnosed with CRC and 80 from patients without CRC attending surgical clinic of SASMEC@IIUM were collected and analyzed with iFOBT test and PCR assay to detect <em>S. gallolyticus</em>.</p></div><div><h3>Results</h3><p>In this study, the proportion of <em>S. gallolyticus</em><span> infection was higher among patients with CRC (48.5%) compared with the control group (20%). Univariate analysis<span> shows that occult blood in stool, </span></span><em>S. gallolyticus</em> infection and family history were significantly associated with the development of CRC (<em>P</em><span> &lt; 0.05). Using the multivariate logistic regression model, positive stool PCR for </span><em>S. gallolyticus</em> had the lowest relative standard error and almost five times the odds of developing CRC after adjusting other factors (adjusted odds ratio = 4.7, 95% confidence interval = 1.7–12.6, relative standard error = 59.6%).</p></div><div><h3>Conclusion</h3><p>This finding suggests that <em>S. gallolyticus</em><span> infection was the strongest predictor of CRC’s development in our study and potentially serves as a predictive marker<span> for early detection of disease progression.</span></span></p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9800914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ileal perforation due to migrated biliary stent: A case report 胆道支架移位致回肠穿孔1例报告。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2023.08.002
Lujain AlZoubi , Basem Badwan , Ahmad Fayyad

Ileal perforation caused by the migration of a biliary stent is a rare complication that can occur during endoscopic stent placement for benign or malignant biliary tract diseases. The current study reports the case of a 45-year-old woman with a history of Endoscopic retrograde cholangiopancreatography (ERCP) in which a migrated biliary stent resulted in an ileal perforation.

胆道支架移位引起的回肠穿孔是一种罕见的并发症,可在良性或恶性胆道疾病的内镜支架置入过程中发生。本研究报告了一例45岁女性,有内镜逆行胰胆管造影(ERCP)病史,其中移位的胆道支架导致回肠穿孔。
{"title":"Ileal perforation due to migrated biliary stent: A case report","authors":"Lujain AlZoubi ,&nbsp;Basem Badwan ,&nbsp;Ahmad Fayyad","doi":"10.1016/j.ajg.2023.08.002","DOIUrl":"10.1016/j.ajg.2023.08.002","url":null,"abstract":"<div><p>Ileal perforation caused by the migration of a biliary stent is a rare complication that can occur during endoscopic stent placement<span><span> for benign or malignant biliary tract diseases. The current study reports the case of a 45-year-old woman with a history of </span>Endoscopic retrograde cholangiopancreatography (ERCP) in which a migrated biliary stent resulted in an ileal perforation.</span></p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10226377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Hypersplenism and thrombocytopenia after exposure to ustekinumab in a patient with Crohn’s disease” [Arab J. Gastroenterol. 23 (2022) 288–289] 更正“克罗恩病患者暴露于ustekinumab后的脾功能亢进和血小板减少症”[Arab J.Gastroenterol.23(2022)288-289]。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2023.06.001
Mansour A. Altuwaijri , Maha J. Aljasser
{"title":"Corrigendum to “Hypersplenism and thrombocytopenia after exposure to ustekinumab in a patient with Crohn’s disease” [Arab J. Gastroenterol. 23 (2022) 288–289]","authors":"Mansour A. Altuwaijri ,&nbsp;Maha J. Aljasser","doi":"10.1016/j.ajg.2023.06.001","DOIUrl":"10.1016/j.ajg.2023.06.001","url":null,"abstract":"","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10172830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preloading guidewire method: EUS-guided hepaticogastrostomy 预载导丝法:EUS引导肝胃造瘘术。
IF 1.4 4区 医学 Q3 Medicine Pub Date : 2023-08-01 DOI: 10.1016/j.ajg.2023.06.002
Hirotsugu Maruyama, Yuki Ishikawa-Kakiya, Kojiro Tanoue, Akira Higashimori, Yasuhiro Fujiwara
{"title":"Preloading guidewire method: EUS-guided hepaticogastrostomy","authors":"Hirotsugu Maruyama,&nbsp;Yuki Ishikawa-Kakiya,&nbsp;Kojiro Tanoue,&nbsp;Akira Higashimori,&nbsp;Yasuhiro Fujiwara","doi":"10.1016/j.ajg.2023.06.002","DOIUrl":"10.1016/j.ajg.2023.06.002","url":null,"abstract":"","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9929356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arab Journal of Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1